Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review
- PMID: 32227127
- PMCID: PMC7483894
- DOI: 10.1001/jamainternmed.2020.0555
Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review
Abstract
Importance: The requirement of prolonged intravenous antibiotic courses to treat infective endocarditis (IE) is a time-honored dogma of medicine. However, numerous antibiotics are now available that achieve adequate levels in the blood after oral administration to kill bacteria. Moreover, prolonged intravenous antibiotic regimens are associated with high rates of adverse events. Accordingly, recent studies of oral step-down antibiotic treatment have stimulated a reevaluation of the need for intravenous-only therapy for IE.
Observations: PubMed was reviewed in October 2019, with an update in February 2020, to determine whether evidence supports the notion that oral step-down antibiotic therapy for IE is associated with inferior outcomes compared with intravenous-only therapy. The search identified 21 observational studies evaluating the effectiveness of oral antibiotics for treating IE, typically after an initial course of intravenous therapy; none found such oral step-down therapy to be inferior to intravenous-only therapy. Multiple studies described an improved clinical cure rate and an improved mortality rate among patients treated with oral step-down vs intravenous-only antibiotic therapy. Three randomized clinical trials also demonstrated that oral step-down antibiotic therapy is at least as effective as intravenous-only therapy in right-sided, left-sided, or prosthetic valve IE. In the largest trial, at 3.5 years of follow-up, patients randomized to receive oral step-down antibiotic therapy had a significantly improved cure rate and mortality rate compared with those who received intravenous-only therapy.
Conclusions and relevance: This review found ample data demonstrating the therapeutic effectiveness of oral step-down vs intravenous-only antibiotic therapy for IE, and no contrary data were identified. The use of highly orally bioavailable antibiotics as step-down therapy for IE, after clearing bacteremia and achieving clinical stability with intravenous regimens, should be incorporated into clinical practice.
Conflict of interest statement
Figures
Similar articles
-
Oral antibiotic therapy in infective endocarditis.Ann Pharmacother. 1996 Jun;30(6):676-8. doi: 10.1177/106002809603000617. Ann Pharmacother. 1996. PMID: 8792956
-
Oral antibiotics for infective endocarditis: a clinical review.J Antimicrob Chemother. 2020 Aug 1;75(8):2021-2027. doi: 10.1093/jac/dkaa106. J Antimicrob Chemother. 2020. PMID: 32240296 Review.
-
Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study.Eur Heart J. 2023 Dec 21;44(48):5095-5106. doi: 10.1093/eurheartj/ehad715. Eur Heart J. 2023. PMID: 37879115 Clinical Trial.
-
Partial oral antibiotic therapy is non-inferior to intravenous therapy in non-critically ill patients with infective endocarditis : Review and meta-analysis.Wien Klin Wochenschr. 2020 Dec;132(23-24):762-769. doi: 10.1007/s00508-020-01614-z. Epub 2020 Feb 10. Wien Klin Wochenschr. 2020. PMID: 32040621 Free PMC article. Review.
-
Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials.BMJ Open. 2020 Jul 14;10(7):e033540. doi: 10.1136/bmjopen-2019-033540. BMJ Open. 2020. PMID: 32665381 Free PMC article.
Cited by
-
Prolonged outpatient parenteral antimicrobial treatment: frequency and evolution over a six-year period in a Swiss University Hospital.BMC Infect Dis. 2024 Nov 7;24(1):1255. doi: 10.1186/s12879-024-10170-0. BMC Infect Dis. 2024. PMID: 39511471 Free PMC article.
-
Native Infective Endocarditis: A State-of-the-Art-Review.Microorganisms. 2024 Jul 19;12(7):1481. doi: 10.3390/microorganisms12071481. Microorganisms. 2024. PMID: 39065249 Free PMC article. Review.
-
''Myth Busting in Infectious Diseases'': A Comprehensive Review.Cureus. 2024 Mar 30;16(3):e57238. doi: 10.7759/cureus.57238. eCollection 2024 Mar. Cureus. 2024. PMID: 38686221 Free PMC article. Review.
-
Personalising intravenous to oral antibiotic switch decision making through fair interpretable machine learning.Nat Commun. 2024 Jan 13;15(1):506. doi: 10.1038/s41467-024-44740-2. Nat Commun. 2024. PMID: 38218885 Free PMC article.
-
Trends of Infective Endocarditis at Two Teaching Hospitals: A 12-Year Retrospective Cohort Study in Rio de Janeiro, Brazil.Trop Med Infect Dis. 2023 Dec 12;8(12):516. doi: 10.3390/tropicalmed8120516. Trop Med Infect Dis. 2023. PMID: 38133448 Free PMC article.
References
-
- Northey EH. The Sulfonamides and Allied Compounds. Reinhold Publishing, Inc; 1948.
-
- Lichtman SS. Treatment of subacute bacterial endocarditis: current results. Ann Intern Med. 1943; 19:787–704. doi:10.7326/0003-4819-19-5-787 - DOI
-
- Marshall EK, Emerson K Jr, Cutting WC. Para-aminobenzenesulfonamide: absorption and excretion: method of determination in urine and blood. JAMA. 1937;108:953–957. doi:10.1001/jama.1937.02780120023005 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
